Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more

Recent & Breaking News (NDAQ:MYGN)

Investor Alert: Kaplan Fox Announces Investigation Of Myriad Genetics, Inc.

PR Newswire May 3, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018

Business Wire May 3, 2018

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Myriad Genetics, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire May 3, 2018

Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers

GlobeNewswire May 2, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Myriad Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 – MYGN

GlobeNewswire April 30, 2018

Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Myriad Genetics, Inc.

Business Wire April 30, 2018

MYGN LOSS NOTICE: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action – MYGN

Business Wire April 29, 2018

MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN

PR Newswire April 27, 2018

RM LAW Announces Class Action Lawsuit Against Myriad Genetics, Inc.

PR Newswire April 27, 2018

The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Myriad Genetics, Inc.

Business Wire April 26, 2018

Robbins Arroyo LLP: Myriad Genetics, Inc. (MYGN) Misled Shareholders According to a Recently Filed Class Action

Business Wire April 25, 2018

The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Myriad Genetics, Inc. (MYGN)

Business Wire April 25, 2018

Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against Myriad Genetics, Inc. (MYGN)

PR Newswire April 25, 2018

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Myriad Genetics, Inc.

Business Wire April 24, 2018

Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis Therapeutics, Inc., Under Armour, Inc. and United Community Bancor

PR Newswire April 24, 2018

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc.

Business Wire April 23, 2018

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Myriad Genetics, Inc. Investors (MYGN)

Business Wire April 23, 2018

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Contact the Firm

Business Wire April 23, 2018

Myriad Genetics Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. - MYGN

PR Newswire April 23, 2018

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Myriad Genetics, Inc.

Business Wire April 23, 2018
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested